Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma

NCT03522298 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma, Adult

Interventions

DRUG: Paxalisib (GDC-0084)

Sponsor

Kazia Therapeutics Limited